Pharmacist's Letter Canada | Convenient Monthly Updates + CE

February 2025 Issue

Be Familiar With the Latest Pneumococcal Vaccine

Pneumococcal 21-valent conjugate vaccine (Capvaxive) will be another option for pneumococcal vaccination in adults 18 years and up...

Resources

Chart: Comparison of Pneumococcal Vaccines

Answer Questions About the New Insulin Device, InsuJet

You’ll hear chatter about InsuJet, the first needle-free insulin injection device for patients 6 years and up with diabetes in Canada...

Protect Your Pharmacy From the Next Scam

Pharmacy scams can lead to stealing of sensitive info, money, and medications from prescribers and pharmacies...

Bottoms Up! Help Sort Out Bowel Prep Options

You can help patients succeed with bowel preps for colonoscopies...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: Managing Burnout and Prioritizing Self-Care

CE-IN-THE-LETTER: Pharmacist's Letter Canada February 2025

LIVE CE: Pharmacy Essential Updates February 2025

PODCAST CE: Medication Talk - Notable New Meds of 2024

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

21-valent pneumococcal conjugate vaccine (PCV21) (Capvaxive)

GO TO ALL CLINICAL RESOURCES >

What is Pharmacist's Letter Canada?

Pharmacist's Letter Canada is the resource trusted by over 200,000 pharmacists for staying current on medication recommendations and taking and tracking CE. Learn more >

Developing Your Pharmacy Career

Pharmacist's Letter Canada is one of many CE and training solutions from TRC Healthcare. We support pharmacists like you at all stages of their career. Learn more about:

Advanced Resources for Natural Medicines
Training on Diabetes Monitoring and Management for Pharmacists

Group Purchases & Pricing

Pharmacist’s Letter Canada is eligible for bulk discounts. Easily manage staff access and customize CE & training assignments. Bundle with other products for significant savings. Request information